Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-08-Speech-3-072"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20100908.4.3-072"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, first of all, I would like to thank you for your comments and the general support for the provisions included in this directive.
We have before us an ambitious directive that, if adopted, will significantly improve animal welfare in the EU. I agree with Ms Sârbu that full and faithful implementation will be key for the directive to fulfil its potential. That challenge is just beginning. Today, we can be satisfied that a good compromise has been reached on a difficult but important file, and that a big step forward can be made on improving the lives of animals still needed in scientific procedures.
I will now give my reactions to some of the comments that were made this morning. Regarding the comments made by Ms Evans, it has to be realised that this directive provides further legal clarity to today’s situation. In addition, in basic and applied research for which no EU methods are prescribed, Article 4 is very clear in requiring the use of alternative methods wherever possible. Therefore, the requirement to use alternative methods is not weakened; on the contrary, it is further strengthened.
As for the comments made by Mr Kastler and Mr Mikolášik about human embryonic stem cells, this matter was not disregarded in the discussions. It was discussed at length during the negotiations, and the solutions found reflect the fact that there is no consensus in the EU as to whether human embryonic stem cells should be used. The Commission therefore believes this is best regulated at national level.
The agreed text answers these concerns by leaving the decision on whether to allow their use to each individual Member State. It must be added that, in Member States where there is no explicit legislation prohibiting the use of embryonic stem cells, the use of such a testing method would only be obligatory under the revised directive if this testing method were recognised by EU legislation. No legislation of this kind exists at EU level, and any such legislation would require Member States to agree to its being passed.
As for the ethical evaluation mentioned by Ms Gardini, the concept of ethical evaluation and the committee carrying it out remain firmly in Article 38. However, the word ‘ethical’ had to be removed during the Council discussions. The full requirement remains.
I hope that, with your vote, you will send a strong signal that the European Parliament stands behind the outcome negotiated by the institutions under the skilful leadership of Ms Jeggle and the Swedish Presidency. Today, we have the chance to bring the EU to the forefront in combining a high level of animal welfare with quality science. Let us live up to our slogan: ‘The EU – caring for animals, aiming for better science’."@en1
|
| lpv:unclassifiedMetadata | |
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples